Table 2 Pretherapeutic patients` characteristics
Age | ||
- Median (range 38–83) | 67 | |
- < 65 | 38 | 39% |
- ≥ 65 | 60 | 61% |
Sex | ||
- Male | 45 | 46% |
- Female | 53 | 54% |
Surgery | ||
- Stereotactic biopsy | 60 | 61% |
- Open biopsy | 19 | 19% |
- Partial resection | 5 | 5% |
- Complete resection | 11 | 11% |
- Vitreal cytology | 2 | 2% |
- CSF cytology | 1 | 1% |
Neuropathologial Diagnosis | ||
- Diffuse large-cell B-cell lymphoma | 92 | 94% |
- Lymphoma, not specified | 6 | 6% |
- Other | 0 | |
CSF diagnostic | ||
- elevated cell count | 26/82 | 32% |
- elevated CSF protein | 45/80 | 56% |
- lymphoma cells in CSF cytology | 10/74 | 14% |
- lymphoma cells in flow cytometry | 3/53 | 6% |
Karnofsky-Performance Score | ||
- median (range 20–100) | 60 | |
- ≥ 70 | 45 | 46% |
- < 70 | 53 | 54% |
MSKCC Score | ||
- ≤ 50 years | 9 | 9% |
- > 50 years/KPS ≥ 70 | 39 | 40% |
- > 50 years/KPS ≥ 70 | 50 | 51% |
IELSG Score | ||
- score 0–1 | 11/74 | 15% |
- score 2–3 | 40/74 | 54% |
- score 4–5 | 23/74 | 31% |